Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Transgender and gender-diverse teens need specialized skin and mental health care.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Transgender individuals can maintain stable kidney function post-transplant with gender-affirming care, but need careful management of hormone therapy risks and regular health screenings.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Uterine transplants for transgender women are feasible but need more research.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.